Zobrazeno 1 - 10
of 158
pro vyhledávání: '"Drew, Moghanaki"'
Autor:
Trudy C. Wu, Alan Lee, Robert Suh, Talia C. Oughourlian, Fereidoun Abtin, Mary Ann Hagio, Sang-June Park, Albert J. Chang, Drew Moghanaki
Publikováno v:
Journal of Contemporary Brachytherapy, Vol 16, Iss 2, Pp 150-155 (2024)
Patients with primary tumor progression after stereotactic body radiation therapy (SBRT) for stage I non-small cell lung cancer (NSCLC) have a second chance at complete tumor eradication with salvage local therapies, including lung resection, repeat
Externí odkaz:
https://doaj.org/article/72650a1c8f0344838c617283a549a4ca
Autor:
John Nikitas, MD, Jane Yanagawa, MD, Sandra Sacks, MD, Edward K. Hui, MD, Alan Lee, MD, Jie Deng, MD, PhD, Fereidoun Abtin, MD, Robert Suh, MD, Jay M. Lee, MD, Paul Toste, MD, Bryan M. Burt, MD, Sha’Shonda L. Revels, MD, Robert B. Cameron, MD, Drew Moghanaki, MD, MPH
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 7, Pp 100690- (2024)
Chest wall pain syndromes can emerge following local therapies for lung cancer and can adversely affect patients’ quality-of-life. This can occur after lung surgery, radiation therapy, or percutaneous image-guided thermal ablation. This review desc
Externí odkaz:
https://doaj.org/article/85c77404d66d415ea5279354dac37aad
Autor:
William A. Stokes, Madhusmita Behera, Renjian Jiang, David A. Gutman, Zhonglu Huang, Abigail Burns, Nikhil T. Sebastian, Vidula Sukhatme, Michael C. Lowe, Suresh S. Ramalingam, Vikas P. Sukhatme, Drew Moghanaki
Publikováno v:
Cancer Medicine, Vol 12, Iss 1, Pp 358-367 (2023)
Abstract Background Peroxisome proliferator‐activated receptor agonists such as fibrates restore oxidative metabolism in cytotoxic T‐lymphocytes, thereby enhancing response to immune checkpoint inhibitors (ICI) in preclinical models. However, the
Externí odkaz:
https://doaj.org/article/38bd7141aeb7447eb83d8b4d4ffa906d
Autor:
Thomas E. Strayer, Lucy B. Spalluto, Abby Burns, Christopher J. Lindsell, Claudia I. Henschke, David F. Yankelevitz, Drew Moghanaki, Robert S. Dittus, Timothy J. Vogus, Carolyn Audet, Sunil Kripalani, Christianne L. Roumie, Jennifer A. Lewis
Publikováno v:
Implementation Science Communications, Vol 4, Iss 1, Pp 1-16 (2023)
Abstract Background Lung cancer screening is a complex clinical process that includes identification of eligible individuals, shared decision-making, tobacco cessation, and management of screening results. Adaptations to the delivery process for lung
Externí odkaz:
https://doaj.org/article/6771b798517e425193a85de5ef57be9c
Autor:
Hann‐Hsiang Chao, Payal D. Soni, Bassam Dahman, Spiro C. Stilianoudakis, Hampton Ford, Raj Singh, Stephen J. Freedland, Drew Moghanaki, Neha Vapiwala, Michael G. Chang
Publikováno v:
Cancer Medicine, Vol 11, Iss 15, Pp 2886-2895 (2022)
Abstract Background The optimal upfront treatment modality for patients with nonmetastatic Gleason Score 9 and 10 prostate cancer (GS 9–10 PCa) is unknown. Methods We conducted a retrospective cohort study of patients in the Veterans Health Adminis
Externí odkaz:
https://doaj.org/article/0a7ff5dfc9c54cf9aaf433619ea74a42
Autor:
Clayton P. Smith, MD, Michael Xiang, MD, PhD, Stephanie M. Yoon, MD, Alan Lee, MD, Dan Ruan, PhD, Jonathan W. Goldman, MD, Amy L. Cummings, MD, Aaron Lisberg, MD, Edward B. Garon, MD, MS, Drew Moghanaki, MD, MPH
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 3, Pp 100468- (2023)
Introduction: Osimertinib is an effective treatment for metastatic NSCLC. Occasionally, thoracic radiation therapy (TRT) is delivered to patients receiving osimertinib to treat residual or progressing pulmonary tumors. Anecdotal reports suggest that
Externí odkaz:
https://doaj.org/article/b2b61572fb9f435fa78b46c90498509e
Autor:
Jenny L. Donovan, Marcus Jepson, Leila Rooshenas, Sangeetha Paramasivan, Nicola Mills, Daisy Elliott, Julia Wade, Domenic Reda, Jane M. Blazeby, Drew Moghanaki, E. Shelley Hwang, Louise Davies
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-14 (2022)
Abstract Background Many randomised controlled trials (RCTs) struggle to recruit, despite valiant efforts. The QRI (QuinteT Recruitment Intervention) uses innovative research methods to optimise recruitment by revealing previously hidden barriers rel
Externí odkaz:
https://doaj.org/article/8ead252c2c08440097d981bf538be64e
Autor:
Luca F. Valle, MD, Fang-I Chu, PhD, Marc Smith, PhD, Chenyang Wang, MD PhD, Percy Lee, MD, Drew Moghanaki, MD MPH, Fumiko L. Chino, MD, Michael L. Steinberg, MD, Ann C. Raldow, MD MPH
Publikováno v:
Advances in Radiation Oncology, Vol 7, Iss 6, Pp 100919- (2022)
Purpose: Both the superstructures of virtual discourse in radiation oncology and the entities occupying influential positions in the social media landscape of radiation oncology remain poorly characterized. Methods and Materials: NodeXL Pro was used
Externí odkaz:
https://doaj.org/article/c134031b5b8b4037bb1d32aead175c3a
Autor:
Stephanie M. Yoon, Robert Suh, Fereidoun Abtin, Drew Moghanaki, Scott Genshaft, Mitchell Kamrava, Alexandra Drakaki, Sandy Liu, Puja Venkat, Alan Lee, Albert J. Chang
Publikováno v:
Radiation Oncology, Vol 16, Iss 1, Pp 1-9 (2021)
Abstract Background Centrally located lung tumors present treatment challenges given their proximity to mediastinal structures including the central airway, esophagus, major vessels, and heart. Therapeutic options can be limited for medically inopera
Externí odkaz:
https://doaj.org/article/774901fed6d54a3da825ceae436d7b82
Autor:
Neal S. McCall, MD, Yuan Liu, PhD, Sagar A. Patel, MD, Bruce Hershatter, MD, Drew Moghanaki, MD, Karen D. Godette, MD, Sheela Hanasoge, MD, PhD, Pretesh Patel, MD, Benjamin W. Fischer-Valuck, MD, Joseph W. Shelton, MD, Ashesh B. Jani, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 6, Pp 100803- (2021)
Purpose: Treatment with long-term androgen deprivation therapy (ADT) and radiation therapy (RT) is the nonsurgical standard-of-care for patients with high- or very high-risk prostate cancer (HR-PC), but the optimal timing between ADT and RT initiatio
Externí odkaz:
https://doaj.org/article/510c544551994ec9be4490c754652515